share_log

EXCLUSIVE: Next-Generation Psychedelics, MEAI - How And Why, An Israeli Scientist Explains

EXCLUSIVE: Next-Generation Psychedelics, MEAI - How And Why, An Israeli Scientist Explains

独家:下一代迷幻药,MEAI——一位以色列科学家解释了如何和为什么
Benzinga Real-time News ·  2023/01/23 11:28
(This is part two of a four-part series)
(这是由四部分组成的系列的第二部分)
Check out part one in the series: Next-Generation Psychedelics: The Case Of MEAI And Its Potential To Treat Addiction
查看该系列的第一部分: 下一代迷幻药:MEAI的案例及其治疗成瘾的潜力
A compound developed by Israeli psychedelics company Clearmind Medicine (NASDAQ:CMND) would act by providing a similar feeling to that which drinking alcohol produces.
以色列迷幻药公司Clearmind Medicine(纳斯达克股票代码:CMND)开发的一种化合物的作用是提供与饮酒产生的感觉相似的感觉。
"It gives you the sensation not only that you've had enough but also you don't want to have any more drinks, while also giving a very warm, very controlled sociable sensation," says CEO Dr. Adi Zuloff-Shani.
首席执行官说:“它不仅让你感觉自己已经喝够了,而且你不想再喝点酒,同时还给人一种非常温暖、非常可控的社交感觉。” 阿迪·祖洛夫-沙尼博士。
Clearmind has already concluded several preclinical studies on...
Clearmin...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发